eNauka - pregled

Pregled prema Autor Tomasevic, Zoran M

Prikaz rezultata 1 do 20 od 26  sledeće >
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2010Aggressive Fibromatosis Treated with Combination of Cvp and Tamoxifen: a Case Series Update AnalysisTomasevic, Zoran M; Ristic, Dusan J; Tomasevic, Zorica I  ; Borojevic, Nenad D; Jelic, Svetislav BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2003ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosusSuvajdzic, Nada D  ; Stojanovic-Milenkovic, Roksanda; Tomasevic, Zoran M; Cemerikic-Martinovic, Vesna M; Mihaljevic, Biljana S ; Atkinson, Henry DENaučni članak
23M23 - Rad u međ. časopisu
2019AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan) (✓)Todorovic, Vladimir; ...; Babovic, Nada Lj; ...; Četniković, Bojana; Ceric, Timur; ...; Dzamic, Zoran M  ; Dzodic, Radan R  ; Eri, Živka ;
...; Knežević-Ušaj, Slavica F ; Kovcin, Vladimir N; ...; Markovic, Ivan Z; Markovic, Milan; Mijalkovic, Nenad; ...; Pantelic, Aleksandra; Popović, Lazar S  ; Radosavljevic, Davorin Z; ...; Radulovic, Sinisa S; ...; Rosic, Ivana; ...; Stamatović, Ljiljana  ; ...; Tesanovic, Dusanka D; Tomasevic, Zorica I  ; Tomasevic, Zoran M; ...; Vasovic, Suzana; Vicko, Ferenc  ; ...; Zarić, Bojan  ; ...; (broj, koautora 65);
Naučni članak
23M23 - Rad u međ. časopisu
2009Brain metastases as late breast cancer relapse. Single institution experience and review of the literatureTomasevic, Zoran M; Radosevic-Jelic, Ljiljana M; Jovanovic, Danica; Milovanovic, Zorka M; Tomasevic, Zoran M; Jezdic, Svetlana D; Borojevic, Nenad DNaučni članak
23M23 - Rad u međ. časopisu
2010Breast Cancer Metastases in the Liver and Lungs: to Resect Or Not to Resect?Tomasevic, Zoran M; Nikolic, Srdjan S; Inic, Momcilo M; Jevric, Marko; Zegarac, Milan; Milovanovic, Zorka M; Pupic, Gordana S; Tomasevic, Zoran M; Martinovic, AleksandarKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2010CHARACTERISTICS OF INFLAMMATORY BREAST CANCER PATIENTS WHO FAILED TO SHOW RESPONSE TO INDUCTION CHEMOTHERAPYKolarevic, Daniela; Tomasevic, Zoran M; Borojevic, Nenad D; Jelic, Svetislav BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2018Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indicationsKolberg, Hans-Christian; Tomasevic, Zoran M; Demetriou, Georgia S; von, Minckwitz Gunter; Fujiwara, Yasuhiro; Ponomarova, O; Tesch, Hans; Santi, Patricia Xavier; Hanes, VladimirKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2009Comparison between Steroid Receptors and Her2 Status in Primary Breast Carcinoma and Completely Resected Breast Carcinoma Metastases from Different Visceral Organ SitesTomasevic, Zorica I  ; Nikolic, Srdjan S; Jevric, Marko; Pupic, Gordana S; Milovanovic, Zorka M; Skender, Milica K ; Inic, Momcilo M; Tomasevic, Zoran M; Djodic, R; Zegarac, Milan;
Vasovic, Suzana; Jelic, Svetislav B;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2010Comparison of hormone receptor and HER2 status in resected brain metastases and primary breast cancer.Tomasevic, Zoran M; Milovanovic, Zorka M; Tomasevic, Zoran M; Skender, Milica K ; Pupic, Gordana S; Kovac, Zeljko; Grujicic, Danica MKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2010COMPARISON OF MEDIAN TIME TO BRAIN METASTASES DEVELOPMENT IN TRIPLE NEGATIVE BC AND HER2 3+BCTomasevic, Zorica I  ; Kovac, Zeljko; Tomasevic, Zoran M; Milovanovic, Zorka MKonferencijski rad
Mp kategorija će biti prikazana naknadno.
1999Epirubicin 150 mg/m(2)-cisplatin versus epirubicin 180 mg/m(2)-cisplatin for advanced soft tissue sarcomaJelic, Svetislav B; Babovic, Nada Lj; Kreacic, Miroslav; Matkovic, Suzana; Milanovic, Nenad; Gavrilovic, Dusica; Tomasevic, Zoran MNaučni članak
23M23 - Rad u međ. časopisu
2010EVALUATION OF PROGNOSTIC VALUE OF HER2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION FOR PREDICTING EARLY FAILURE IN PATIENTS WITH OPERABLE BREAST CANCERVasovic, Suzana; Stamatovic, Ljiljana; Tomasevic, Zoran M; Karaferic, Andjela; Pavlovic, L; Karadzic, Katarina; Jovanic, Irena PKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2005Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysisNikolic-Tomasevic, Zorica I  ; Jelic, Svetislav B; Cassidy, Jonathan; Filipovic-Ljeskovic, Ivana M; Tomasevic, Zoran MNaučni članak
22M22 - Rad u istaknutom međ. časopisu
2019HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinibTomasevic, Zoran M; Smyth, LM; Saura, C; Boni, V; Garcia-Saenz, JA; Prat, A; Eli, L; Garza, SJ; Lalani, AS; Crown, JPKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2013Ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for transplant-ineligible aggressive non-Hodgkin lymphoma patients - long term surveillanceMilanovic, Nenad; Ristic, Dusan J; Puric, Mila; Tomasevic, Zoran MKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Long-term trastuzumab treatment in HER2 positive metastatic breast cancerCalamac, Marina; Minic, Ivana Z; Tomasevic, Zoran M; Oblakovic-Babic, Jelena S; Serovic, Kristina; Djurmez, Ognjen; Dimitrijevic, M; Bozovic-Spasojevic, Ivana MKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2019Matching the critical function of the biosimilar ABP 980 and trastuzumab: Totality of evidence and scientific justification for extrapolation across trastuzumab indicationsKolberg, Hans-Christian; Colleoni, Marco A; Tomasevic, Zoran M; Ponomarova, O; McBride, HJ; Tesch, Hans; Hanes, VladimirKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2010Mutational and clinicopathological analysis of papillary thyroid carcinoma in Serbian patientsStanojevic, Boban R  ; Dzodic, Radan R  ; Saenko, Vladimir; Milovanovic, Zorka M; Pupic, Gordana S; Zivkovic, Ognjen; Markovic, Ivan Z; Djurisic, Igor; Buta, Marko N  ; Tomasevic, Zoran M;
Rogounovitch, Tatiana; Mitsutake, Norito; Mine, Mariko; Shibata, Yoshisada; Yamashita, Shunichi;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2017Neratinib after trastuzumab (T)-based adjuvant therapy in early-stage HER2+breast cancer (BC): 5-year analysis of the phase III ExteNET trialJimenez, Martin M; ...; Tomasevic, Zoran M; ...; (broj, koautora 20)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Our experience with COVID-19 infection in oncology patientsDjurmez, Ognjen; Calamac, Marina; Dimitrijevic, M; Serovic, Kristina; Oblakovic-Babic, Jelena S; Minic, Ivana Z; Tomasevic, Zoran M; Bozovic-Spasojevic, Ivana MKonferencijski rad
Mp kategorija će biti prikazana naknadno.